A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Study Identifier
190342-038
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact

Results Available

Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English

Study Details

Medical Condition
  • Macular Degeneration - Other
  • Study Drug
  • 400 µg Brimonidine Implant
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    55+ years

    Protocol Summary

    This study will assess the safety and efficacy of the brimonidine intravitreal implant in participants with geographic atrophy due to age-related macular degeneration.

    Study Locations

    Location
    Status
    Location
    Retinal Consultants of Arizona, Ltd., Retinal Research Institute
    Phoenix, Arizona, United States, 85014
    Status
    Not applicable
    Location
    Associated Retina Consultants
    Phoenix, Arizona, United States, 85020
    Status
    Not applicable
    Location
    University of California, San Diego, Jacobs Retina Center, Shiley Eye Center
    La Jolla, California, United States, 92037
    Status
    Not applicable
    Location
    Northern California Retina Vitreous Associates
    Mountain View, California, United States, 94040
    Status
    Not applicable
    Location
    Retina Consultants of Southern Colorado, PC
    Colorado Springs, Colorado, United States, 80909
    Status
    Not applicable
    Location
    "National Ophthalmic Research Institute Retina Consultants of Southwest Florida"
    Fort Myers, Florida, United States, 33912
    Status
    Not applicable
    Showing {first} - {last} of {total} Results